Anna Morera - Wuhan General Chief Medical Officer
| WUHNDelisted Stock | USD 0.0004 0.00 0.00% |
Executive
Dr. Anna Leralta Morera is Secretary and Chief Medical Officer, Director of the Company. Dr. Anna has established herself as a dedicated researcher, thought leader and medical practitioner in the medical cannabis field. She is relentless in advancing the medical community understanding of cannabis and cannabinoids and ultimately in being able to provide society with alternative options to what are now standard practices. Her research to date has focused on the safety, efficacy, and effectiveness of cannabis and cannabinoids in pain and symptom management. since 2019.
| Tenure | 5 years |
| Phone | 514-928-7368 |
| Web | https://wuhn.org |
Wuhan General Management Efficiency
Wuhan General's management efficiency ratios could be used to measure how well Wuhan General manages its routine affairs as well as how well it operates its assets and liabilities.Wuhan General Gr currently holds 118.8 M in liabilities with Debt to Equity (D/E) ratio of 1.11, which is about average as compared to similar companies. Wuhan General Gr has a current ratio of 1.08, suggesting that it may not have the ability to pay its financial obligations when due. Debt can assist Wuhan General until it has trouble settling it off, either with new capital or with free cash flow. So, Wuhan General's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Wuhan General Gr sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Wuhan to invest in growth at high rates of return. When we think about Wuhan General's use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Allan Cleiren | Aurora Cannabis | N/A | |
| Mark Ware | Canopy Growth Corp | N/A | |
| Anna Shlimak | Cronos Group | 38 | |
| Arye Weigensberg | Cronos Group | 41 | |
| Jenny Brewer | Canopy Growth Corp | N/A | |
| Alex Miller | Aurora Cannabis | N/A | |
| Simona King | Aurora Cannabis | 52 | |
| Sophie Pilon | SNDL Inc | N/A | |
| Jillian Swainson | Aurora Cannabis | N/A | |
| Greg McDonald | SNDL Inc | N/A | |
| Debra Wilson | Aurora Cannabis | N/A | |
| Lori Schick | Aurora Cannabis | N/A | |
| Shannon Buggy | Cronos Group | 54 | |
| Darryl Vleeming | Aurora Cannabis | N/A | |
| Deanna Garand | SNDL Inc | 41 | |
| Terry Doucet | Cronos Group | 34 | |
| Ru Wadasinghe | Canopy Growth Corp | N/A | |
| Matthew Husson | SNDL Inc | 43 | |
| Neil Belot | Aurora Cannabis | N/A | |
| Michelle Lefler | Aurora Cannabis | N/A | |
| Alberto ParederoQuiros | SNDL Inc | 51 | |
Management Performance
| Return On Equity | -0.0878 | ||||
| Return On Asset | -0.005 |
Wuhan General Gr Leadership Team
Elected by the shareholders, the Wuhan General's board of directors comprises two types of representatives: Wuhan General inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Wuhan. The board's role is to monitor Wuhan General's management team and ensure that shareholders' interests are well served. Wuhan General's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Wuhan General's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Anna Morera, Chief Medical Officer | ||
| Carol Pan, Principal Officer | ||
| Luka MSc, Director Communication | ||
| Huang Zhaoqi, Vice Director | ||
| Johann Mcloughlin, Head Design | ||
| Shivani Subudhi, Head Marketing | ||
| Willem Jonker, Chief Officer | ||
| Samuel Williams, Head Foods | ||
| Jeffrey Robinson, Chairman Founder | ||
| AAg MSc, Chief Officer |
Wuhan Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Wuhan General a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.0878 | ||||
| Return On Asset | -0.005 | ||||
| Profit Margin | (0.13) % | ||||
| Operating Margin | (0.03) % | ||||
| Current Valuation | 3.05 M | ||||
| Shares Outstanding | 33.93 M | ||||
| Number Of Shares Shorted | 12.62 K | ||||
| Price To Earning | (0.06) X | ||||
| Price To Book | 0.04 X | ||||
| Price To Sales | 0.05 X |
Pair Trading with Wuhan General
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Wuhan General position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Wuhan General will appreciate offsetting losses from the drop in the long position's value.Moving together with Wuhan Pink Sheet
Moving against Wuhan Pink Sheet
| 0.72 | INIS | International Isotopes | PairCorr |
| 0.54 | ELTP | Elite Pharma | PairCorr |
| 0.45 | YCBD-PA | cbdMD Inc | PairCorr |
| 0.38 | VAXX | Vaxxinity | PairCorr |
The ability to find closely correlated positions to Wuhan General could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Wuhan General when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Wuhan General - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Wuhan General Gr to buy it.
The correlation of Wuhan General is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Wuhan General moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Wuhan General Gr moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Wuhan General can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Consideration for investing in Wuhan Pink Sheet
If you are still planning to invest in Wuhan General Gr check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Wuhan General's history and understand the potential risks before investing.
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |